- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02224625
Irritation and Sensitization of Chlorhexidine Gluconate (CHG) Cloth
Randomized and Observer-blinded Study to Evaluate the Cumulative Irritation and Contact Sensitizing Potential of One Finished Test Product
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
For the Irritation Study (30 subjects), patches containing CHG, vehicle, saline, CHG comparator or sodium lauryl sulfate (a product that is expected to produce a slight skin irritation) will be placed on the same spot of your skin every day for 21 days. The skin will be examined every day.
The Sensitization Study (200 total subjects) place patches containing CHG, vehicle, saline, CHG comparator on the skin 3 times a week for 3 weeks. Following a two-week rest period the patches will be reapplied for 48 hours and assessed out to 72 hours thereafter.
Study Type
Enrollment (Actual)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
Montana
-
Butte, Montana, United States, 59701
- BioScience Laboratories
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Free of skin disorders
- Signed consent
Exclusion Criteria:
- Allergies to latex
- Topical or systemic steroids, antihistamines, antiinflammatory agents 7 days prior or during testing
- severe illness
- Pregnant (females)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 2% CHG Cloth
Chlorhexidine Gluconate 2%
|
Investigational CHG
Other Names:
|
Placebo Comparator: Vehicle Cloth
Excipients on cloth
|
Excipients from CHG cloth only
Other Names:
|
Active Comparator: DynaHex (2% CHG)
Chlorhexidine Gluconate 2% solution
|
Active comparator
Other Names:
|
Sham Comparator: Saline
0.9% sodium chloride
|
Negative control
|
Active Comparator: Sodium Lauryl Sulfate (SLS)
Sodium lauryl sulfate to produce mild irritation as a positive control
|
Provides a slight irritation for a positive control
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Grading Scale for Visual Evaluation of Skin Condition
Time Frame: 21 Days for Irritation (N=39). 35 Days for Sensitization (N=249)
|
Irritation: 21 days of patching (total). A reviewer will assign a score based on an 8 point categorical scale to the areas treated at each visit. Sensitization: 35 days (21 days of patching followed by 14 days rest and subsequent patch). A reviewer will assign a score based on an 8 point categorical scale to the areas treated at each visit. SLS was not tested. Grade 0 = No irritation Grade 1 = Minimal erythema Grade 2 = Definite erythema Grade 3 = Erythema and papules Grade 4 = Edema Grade 5 = Erythema, edema and papules Grade 6 = Vesicular eruption Grade 7 = Strong reaction spreading |
21 Days for Irritation (N=39). 35 Days for Sensitization (N=249)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: J Pullman, MD, BioScience Laboratories
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R13-051
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Surgery
-
3MRecruitingAbdominal Surgery | Orthopedic Surgery | Vascular Surgery | Cardiovascular SurgeryUnited States
-
Vanderbilt UniversityCompletedHand Surgery | Wrist Surgery | Forearm Surgery | Elbow SurgeryUnited States
-
Nantes University HospitalCompletedGynecological Surgery | Plastic Surgery | ENT SurgeryFrance
-
Edwards LifesciencesCompletedAbdominal Surgery | Pelvic Surgery | Non-Cardiac/ Non-Thoracic Surgery | Major Peripheral Vascular SurgeryUnited States
-
Maquet Cardiopulmonary GmbHNAMSARecruitingCardiac Surgery | Cardiopulmonary Bypass | Thoracic Surgery | Vascular SurgerySpain
-
Baylor Research InstituteChiesi USA, Inc.RecruitingSurgery | Cardiac Surgery | Surgery--Complications | Percutaneous Coronary InterventionUnited States
-
Vanderbilt UniversityEdwards LifesciencesCompletedCardiac Surgery | Thoracic Surgery | Heart Surgery | Heart Transplant
-
Poudre Valley Health SystemTerminatedSurgery | Surgery--ComplicationsUnited States
-
EgymedicalpediaCompletedSurgery | Pediatric SurgeryEgypt
-
Cairo UniversityBatterjee Medical College; Taif UniversityCompletedSurgery | Bariatric SurgeryEgypt, Saudi Arabia
Clinical Trials on 2% CHG Cloth solution
-
Icahn School of Medicine at Mount SinaiCompletedEndometritis | Surgical Site Infections | Infection; Cesarean Section | Chlorhexidine Gluconate Cloths | Infectious MorbidityUnited States
-
National Taiwan University HospitalMin-Sheng General Hospital; Lotung Poh-Ai Hospital; Hualien Tzu Chi General Hospital and other collaboratorsRecruiting
-
Catholic University of the Sacred Heart3M; Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, ItalyUnknownInfection | CatheterizationItaly
-
Hacettepe UniversityThe Scientific and Technological Research Council of TurkeyCompletedMRSA Colonization | VRE ColonizationTurkey
-
3MCompleted
-
Angela BiancoStryker NordicTerminatedCesarean Section | Surgical Site Infection | Nosocomial InfectionUnited States
-
Medline IndustriesCompleted
-
3MTerminatedSkin Flora Bacterial Reduction Post-product ApplicationUnited States